Literature DB >> 22508295

First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.

Maria Camila Montealegre1, Juan José Maya, Adriana Correa, Paula Espinal, Maria F Mojica, Sory J Ruiz, Fernando Rosso, Jordi Vila, John P Quinn, Maria Virginia Villegas.   

Abstract

OXA-72 has been reported in few countries around the world. We report the first case in Colombia in an Acinetobacter pittii clinical isolate. The arrival of a new OXA, into a country with high endemic resistance, poses a significant threat, especially because the potential for widespread dissemination is considerable.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22508295      PMCID： PMC3393383          DOI： 10.1128/AAC.05628-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme.

Authors:  A Di Popolo; M Giannouli; M Triassi; S Brisse; R Zarrilli
Journal:  Clin Microbiol Infect       Date:  2011-02       Impact factor: 8.067

2.  Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests.

Authors:  K S Thomson; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

3.  Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania.

Authors:  Guo-Bao Tian; Jennifer M Adams-Haduch; Tatiana Bogdanovich; Anthony W Pasculle; John P Quinn; Hong-Ning Wang; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

4.  Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.

Authors:  Maria Virginia Villegas; Juan Nicolas Kattan; Adriana Correa; Karen Lolans; Ana Maria Guzman; Neil Woodford; David Livermore; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

5.  Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase.

Authors:  I Goic-Barisic; K J Towner; A Kovacic; K Sisko-Kraljevic; M Tonkic; A Novak; V Punda-Polic
Journal:  J Hosp Infect       Date:  2011-02-12       Impact factor: 3.926

6.  Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species.

Authors:  Jane F Turton; Neil Woodford; Judith Glover; Susannah Yarde; Mary E Kaufmann; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.

Authors:  R N Jones; A L Barry; R R Packer; W W Gregory; C Thornsberry
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

8.  A general method for detecting and sizing large plasmids.

Authors:  B M Barton; G P Harding; A J Zuccarelli
Journal:  Anal Biochem       Date:  1995-04-10       Impact factor: 3.365

9.  Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU).

Authors:  Alexandr Nemec; Lenka Krizova; Martina Maixnerova; Tanny J K van der Reijden; Pieter Deschaght; Virginie Passet; Mario Vaneechoutte; Sylvain Brisse; Lenie Dijkshoorn
Journal:  Res Microbiol       Date:  2011-02-12       Impact factor: 3.992

10.  Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.

Authors:  Hui Wang; Ping Guo; Hongli Sun; He Wang; Qiwen Yang; Minjun Chen; Yingchun Xu; Yuanjue Zhu
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191
View more
  13 in total

1.  Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-negatives: the Klebsiella pneumoniae Paradigm.

Authors:  Maria S Ramirez; German M Traglia; David L Lin; Tung Tran; Marcelo E Tolmasky
Journal:  Microbiol Spectr       Date:  2014

2.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in the United States, 2013-2017.

Authors:  Susannah L McKay; Nicholas Vlachos; Jonathan B Daniels; Valerie S Albrecht; Valerie A Stevens; J Kamile Rasheed; J Kristie Johnson; Joseph D Lutgring; Maria Sjölund-Karlsson; Alison Laufer Halpin
Journal:  Microb Drug Resist       Date:  2022-05-27       Impact factor: 2.706

3.  Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

4.  Phenotypic and Genotypic Characteristics of a Tigecycline-Resistant Acinetobacter pittii Isolate Carrying bla NDM-1 and the Novel bla OXA Allelic Variant bla OXA-1045.

Authors:  Zixuan Ding; Zhaoyinqian Li; Yuanqing Zhao; Jingchen Hao; Tingting Li; Yao Liu; Zhangrui Zeng; Jinbo Liu
Journal:  Front Microbiol       Date:  2022-05-04       Impact factor: 5.640

5.  NDM-1 Metallo-β-Lactamase and ArmA 16S rRNA methylase producing Providencia rettgeri clinical isolates in Nepal.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Rajan K Dahal; Manoj K Sah; Hiroshi Ohara; Kayo Shimada; Teruo Kirikae; Bharat M Pokhrel
Journal:  BMC Infect Dis       Date:  2014-02-03       Impact factor: 3.090

6.  First report of Oxa-72-producing Acinetobacter calcoaceticus in Lebanon.

Authors:  A Al Atrouni; M Kempf; M Eveillard; R Rafei; M Hamze; M-L Joly-Guillou
Journal:  New Microbes New Infect       Date:  2015-11-23

7.  Glimpse into the genome sequence of a multidrug-resistant Acinetobacter pittii ST950 clinical isolate carrying the blaOXA-72 and blaOXA-533 genes in China.

Authors:  Zhi Ruan; Yan Chen; Jianfeng Wang
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-10       Impact factor: 2.743

8.  Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon.

Authors:  Tania Nawfal Dagher; Charbel Al-Bayssari; Selma Chabou; Nadine Antar; Seydina M Diene; Eid Azar; Jean-Marc Rolain
Journal:  BMC Microbiol       Date:  2019-02-02       Impact factor: 3.605

9.  Emergence of NDM-1 and OXA-72 producing Acinetobacter pittii clinical isolates in Lebanon.

Authors:  A Al Atrouni; M-L Joly-Guillou; M Hamze; M Kempf
Journal:  New Microbes New Infect       Date:  2016-04-22

Review 10.  Acquired Class D β-Lactamases.

Authors:  Nuno T Antunes; Jed F Fisher
Journal:  Antibiotics (Basel)       Date:  2014-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.